[go: up one dir, main page]

WO2009003001A3 - Preparation of risedronate sodium hemi-pentahydrate - Google Patents

Preparation of risedronate sodium hemi-pentahydrate Download PDF

Info

Publication number
WO2009003001A3
WO2009003001A3 PCT/US2008/068110 US2008068110W WO2009003001A3 WO 2009003001 A3 WO2009003001 A3 WO 2009003001A3 US 2008068110 W US2008068110 W US 2008068110W WO 2009003001 A3 WO2009003001 A3 WO 2009003001A3
Authority
WO
WIPO (PCT)
Prior art keywords
pentahydrate
preparation
risedronate sodium
sodium hemi
hemi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/068110
Other languages
French (fr)
Other versions
WO2009003001A2 (en
Inventor
Vijaya Bhaskar Bolugoddu
Srinivasa Reddy Bhimavarapu
Alekhya Donthula
Shakil Sait
Naresh Tondepu
Chandra Sekhar Ravi Ram Elati
Vara Prasad Sree Naga Vakamudi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Original Assignee
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IN1384CH2007 external-priority patent/IN2007CH01384A/en
Application filed by Dr Reddys Laboratories Ltd, Dr Reddys Laboratories Inc filed Critical Dr Reddys Laboratories Ltd
Publication of WO2009003001A2 publication Critical patent/WO2009003001A2/en
Publication of WO2009003001A3 publication Critical patent/WO2009003001A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Processes for the preparation of risedronate sodium hemi-pentahydrate.
PCT/US2008/068110 2007-06-27 2008-06-25 Preparation of risedronate sodium hemi-pentahydrate Ceased WO2009003001A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1384/CHE/2007 2007-06-27
IN1384CH2007 IN2007CH01384A (en) 2004-10-04 2007-06-27
US3615608P 2008-03-13 2008-03-13
US61/036,156 2008-03-13

Publications (2)

Publication Number Publication Date
WO2009003001A2 WO2009003001A2 (en) 2008-12-31
WO2009003001A3 true WO2009003001A3 (en) 2009-04-02

Family

ID=40186266

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/068110 Ceased WO2009003001A2 (en) 2007-06-27 2008-06-25 Preparation of risedronate sodium hemi-pentahydrate

Country Status (1)

Country Link
WO (1) WO2009003001A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009536639A (en) 2006-05-11 2009-10-15 アイエヌディー−スイフト ラボラトリーズ リミテッド Process for preparing pure risedronic acid or salt

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004037252A1 (en) * 2002-10-25 2004-05-06 Zentiva, A.S. A new crystalline form of the sodium salt of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid
WO2005066190A1 (en) * 2004-01-02 2005-07-21 Hexal A/S New risedronate salts
WO2007036688A1 (en) * 2005-09-30 2007-04-05 Pliva Hrvatska D.O.O. Pharmaceutically acceptable salts and hydrates of risedronic acid

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004037252A1 (en) * 2002-10-25 2004-05-06 Zentiva, A.S. A new crystalline form of the sodium salt of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid
WO2005066190A1 (en) * 2004-01-02 2005-07-21 Hexal A/S New risedronate salts
WO2007036688A1 (en) * 2005-09-30 2007-04-05 Pliva Hrvatska D.O.O. Pharmaceutically acceptable salts and hydrates of risedronic acid

Also Published As

Publication number Publication date
WO2009003001A2 (en) 2008-12-31

Similar Documents

Publication Publication Date Title
WO2009060191A9 (en) Systems for clinical trials
AU2007267535A8 (en) Aziridinyl-epothilone compounds
EP2145397A4 (en) Multi-hop booster
WO2008075205A3 (en) Improved process for the preparation of voriconazole
IL196602A0 (en) Processes for the preparation of montelukast
WO2010039885A3 (en) Crystalline forms of dexlansoprazole
ZA200808011B (en) Process for the isolation of calliterpenone (16alpha, 17-DiHyDroxy-S-Oxo-Phyllocladane)
AU2007234746A8 (en) Naphthalenedione compounds
ZA201003264B (en) Method for the preparation of 2 chloro1,1,1,2,3,3,3 heptafluopropane
WO2009003001A3 (en) Preparation of risedronate sodium hemi-pentahydrate
WO2008058111A3 (en) Methods of preparing halohydroxypropyltrialkylammonium halides
AU2008100909A4 (en) The Challenge of ............
AU2007900709A0 (en) Footwear System
AU2008900799A0 (en) The Termi-Mite Dual Chamber Baiting System
HK1159610A (en) Processes for the preparation of bendamustine
AU2008903010A0 (en) The Levy-traction system
AU2008905466A0 (en) T. Joint
AU2007902302A0 (en) Dowel system
HK1136553A (en) Process for the preparation of rosuvastatin
AU2007904918A0 (en) Maneuvre procedure
AU2006902078A0 (en) Improvent for two-stroke-engines
AU2008903503A0 (en) The unique block
AU2007906387A0 (en) Retrometabolic compounds
AU2007904732A0 (en) Compounds
AU2007902859A0 (en) Ovenmate.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08771880

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08771880

Country of ref document: EP

Kind code of ref document: A2